APA

Lyon T. D., Gershman B., Shah P. H., Thompson R. H., Boorjian S. A., Lohse C. M., Costello B. A., Cheville J. C. & Leibovich B. C. (20190118). Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era. : Urologic oncology.

Chicago

Lyon Timothy D, Gershman Boris, Shah Paras H, Thompson R Houston, Boorjian Stephen A, Lohse Christine M, Costello Brian A, Cheville John C and Leibovich Bradley C. 20190118. Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era. : Urologic oncology.

Harvard

Lyon T. D., Gershman B., Shah P. H., Thompson R. H., Boorjian S. A., Lohse C. M., Costello B. A., Cheville J. C. and Leibovich B. C. (20190118). Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era. : Urologic oncology.

MLA

Lyon Timothy D, Gershman Boris, Shah Paras H, Thompson R Houston, Boorjian Stephen A, Lohse Christine M, Costello Brian A, Cheville John C and Leibovich Bradley C. Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era. : Urologic oncology. 20190118.